RIH receives $11M to continue research

CANCER RESEARCH, LED by Dr. Douglas Hixson at Rhode Island Hospital, has received funding through 2013, thanks to an $11 million grant from the National Institutes of Health. /
CANCER RESEARCH, LED by Dr. Douglas Hixson at Rhode Island Hospital, has received funding through 2013, thanks to an $11 million grant from the National Institutes of Health. /

PROVIDENCE – Rhode Island Hospital has been awarded a five-year, $11 million grant from the National Institutes of Health to support the continuation of the hospital’s COBRE Center for Cancer Research Development.
The center, located in Providence’s Jewelry District, was launched in 2002 with a multi-year $8.4 million grant from the NIH’s National Center for Research Resources.
The latest grant to the Center for Cancer Research Development (CCRD) ensures the laboratory-based program will continue through 2013, the hospital said.
“The renewal of this grant shows the NIH’s recognition of the valuable research being performed here at Rhode Island Hospital’s CCRD,” said Peter Snyder, vice president of research at Lifespan, the health care network that operates Rhode Island Hospital. “In addition, it helps to solidify our role of supporting the Rhode Island economy by increasing the research and biotechnology being done locally.”
Centers of Biomedical Research Excellence (COBRE) augment and strengthen institutional biomedical research capabilities by supporting multidisciplinary centers led by National Institutes of Health-funded investigators with expertise in the program’s focus area.
The Rhode Island Hospital COBRE, led by Dr. Douglas Hixson, offers cancer researchers access to the latest technologies in molecular pathology and the emerging fields of molecular pathology and proteomics, the study of proteins and how they interact and change.
The COBRE also aims to develop the cancer researchers of the future by providing promising young investigators with senior faculty mentors and cutting-edge technologies in biomedical research.
“The renewal of our grant provides us with an outstanding potential for groundbreaking research in our center,” Hixon said. “Of particular interest will be research aimed at identifying characteristics of cancer stem cells that could serve as therapeutic targets. We also expect our new imaging mass spectrometer to become a catalyst for collaborative interactions aimed at developing novel clinical and basic research applications for this largely unexplored technology.”
A hospital official said an $1.84 million award for the research center that was announced last month by U.S. Sen. Jack Reed’s office was actually the first-year installment of the $11 million grant.

Founded in 1863, Rhode Island Hospital is a member of the Lifespan health system, the largest teaching hospital of The Warren Alpert Medical School of Brown University and a research hub with more than $46 million in annual funding, including $27 million from the National Institutes of Health. For more information, go to www.rhodeislandhospital.org.

Beyond Cash Donations: How New Forms of Giving Are Transforming Not-for-Profit Accounting

Evolving Funding Landscape for Not-for-Profits Not-for-profit organizations are being asked to do more with less,…

Learn More

No posts to display